Back

Gut

17 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort
2026-02-27 gastroenterology 10.64898/2026.02.25.26346992
#1 (16.6%)
Show abstract

BackgroundCurrent British Society of Gastroenterology (BSG) guidelines misclassify metachronous lesion risk after polypectomy in approximately 40% of patients. Building on evidence that immune exclusion drives progression of adenomas to colorectal cancer, this study examined immune profiles in screen-detected adenomas as a predictive biomarker for metachronous lesion risk. MethodsPatients undergoing polypectomy within the Scottish Bowel Screening Programme, with surveillance colonoscopy between...

2
Anti-inflammatory effects of 12-HHT via epithelial barrier enhancement in colon organoids of normoganglionosis in Hirschsprungs disease
2026-02-19 gastroenterology 10.64898/2026.02.18.26346528
#1 (9.2%)
Show abstract

PurposeHirschsprung-associated enterocolitis remains a major postoperative complication of Hirschsprungs disease (HD), and impaired epithelial barrier integrity has been proposed as a contributing factor. In this study, we investigated whether 12-hydroxyheptadecatrienoic acid (12-HHT), an endogenous leukotriene B4 receptor 2 (BLT-2) agonist, enhances the epithelial barrier and exerts anti-inflammatory effects in patient-derived colonic organoids. MethodsNormoganglionic specimens from rectal/rec...

3
Potassium-competitive acid channel blockers versus Proton-Pump inhibitors in the prevention of post-endoscopic peptic ulcer rebleeding: A systematic review and meta-analysis
2026-03-06 gastroenterology 10.64898/2026.03.02.26346403
Top 0.2% (6.6%)
Show abstract

Introduction Vonoprazan, a new oral potassium-competitive acid blocker (PCAB), has shown promise in terms of superior acid suppression when compared to Proton pump inhibitors (PPIs). We evaluated the efficacy of PCABs versus PPIs in preventing rebleeding in high-risk peptic ulcer patients after endoscopic hemostasis. Methods Following the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines, we conducted a comprehensive search for relevant studies across Medline...

4
Modified Endoscopic Mucosal Resection Outperforms Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors <=10 mm: A Systematic Review and Meta Analysis
2026-02-11 gastroenterology 10.64898/2026.02.10.26345872
Top 0.3% (6.5%)
Show abstract

BackgroundEndoscopic resection is the standard treatment for rectal neuroendocrine tumors (r-NETs) [&le;]10 mm, yet the optimal technique remains controversial. Modified endoscopic mucosal resection (m-EMR) has emerged as a potential alternative compared to endoscopic submucosal dissection (ESD), but existing evidence is largely retrospective and the results of recent randomized controlled trials (RCTs) are inconclusive. AimsTo compare the efficacy and safety of m-EMR versus ESD for r-NETs [&le...

5
Gestational Environment Captured by the Neonatal Metabolome is not Predictive of Later Inflammatory Bowel Disease
2026-02-18 gastroenterology 10.64898/2026.02.18.26346468
Top 0.3% (6.5%)
Show abstract

BackgroundGestational exposures may contribute to the newborns lifetime risk of inflammatory bowel disease (IBD). While gestational influences are associated with IBD onset, the causality and confounding of such exposures are difficult to ascertain. The neonatal metabolome provides a metabolic snapshot of gestational influences. ObjectiveWe tested the neonatal metabolomes ability to predict future IBD, to assess whether gestational exposures are reflected in early molecular precursors of the di...

6
Prevalence and pre-disposing factors of helicobacter pylori among patients with gastro-intestinal symptoms attending Mulago Hospital, Kampala, Uganda
2026-02-24 gastroenterology 10.64898/2026.02.23.26346905
Top 0.4% (6.4%)
Show abstract

BackgroundComprehensive data on the prevalence of Helicobacter pylori infection and its associated risk factors among patients with gastrointestinal symptoms remain limited. Generating this evidence would help inform clinical management and improve antibiotic stewardship. H. pylori infection affects a substantial proportion of the global population, with prevalence varying widely across regions. In Uganda, previous studies have documented the presence of H. pylori infection. However, data specif...

7
Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn's disease risk
2026-02-22 gastroenterology 10.64898/2026.02.20.26346727
Top 0.4% (6.2%)
Show abstract

ObjectivesTo characterize ultra-processed food (UPF) circulating metabolic signatures associated with Crohns disease (CD) and to localize key metabolic mediators linking UPF intake to CD risk. DesignProspective cohort study. SettingTwo large multi-center cohorts (UK Biobank [UKB] and Whitehall II [WHII] study) across the UK and an Eastern multi-center cohort ONE-IBD Study from China. ParticipantsUK Biobank discovery cohort (n=10,229) for signature derivation, internal validation cohort (n=91,...

8
Body surface colonic mapping detects meal and bisacodyl-induced colonic motility in patients with chronic constipation
2026-02-10 gastroenterology 10.64898/2026.02.08.26345865
Top 0.5% (6.1%)
Show abstract

Chronic constipation is highly prevalent, and cases refractory to treatment are particularly challenging to manage. High-resolution colonic manometry (HRM) is used to further evaluate these patients to identify cases of intrinsic motor dysfunction (underlying myopathy or neuropathy). However, HRM is invasive and resource-intensive, limiting uptake and clinical utility. This study presents Body Surface Colonic Mapping (BSCM), a non-invasive cutaneous electrical recording technique, as a clinical ...

9
Genetic susceptibility versus fibrosis progression in North Indian MASLD: distinct roles of APOC3 and PNPLA3 in a candidate gene study
2026-02-27 gastroenterology 10.64898/2026.02.25.26347059
Top 0.6% (5.6%)
Show abstract

Background and AimMASLD affects 30-38% of Indian adults, yet the contribution of genetic risk variants to disease susceptibility and fibrosis progression remains poorly characterised. We investigated the association of 12 candidate SNPs with MASLD susceptibility and fibrosis severity in North Indian patients, benchmarking allele frequencies against IndiGenomes and global populations. MethodsSixty-nine MASLD patients (75.4% male; median BMI 29.8 kg/m{superscript 2}) from a tertiary care liver cl...

10
Metagenomics AI powered prediction of Inflammatory Bowel Disease and Probiotic Recommendation
2026-02-15 gastroenterology 10.64898/2026.02.12.26345333
Top 0.7% (5.3%)
Show abstract

Background and ObjectiveThe dysbiosis of human gut microbiome has been increasingly seen to have a relation in the development of autoimmune diseases, with specific microbial signatures having causative association with specific conditions. Inflammatory bowel disease (IBD) is one such autoimmune ailment. This paper proposes a predictive tool that can identify the IBD status of an individual based on the composition of the gut microbiome using machine learning and AI agents driven techniques. The...

11
Dysplasia-Stratified Surveillance Identifies Optimal Strategies for Preventing Esophageal Adenocarcinoma in Barrett's Esophagus: An Incidence-Based Cost-Effectiveness Model
2026-02-22 health economics 10.64898/2026.02.17.26346313
Top 0.7% (5.2%)
Show abstract

The risk of esophageal adenocarcinoma (EAC) in Barretts esophagus (BE) varies substantially by segment length and dysplasia grade. This study evaluated the cost-effectiveness and health impacts of dysplasia-stratified EAC surveillance strategies for the Japanese BE population. A state-transition model was developed comparing endoscopy, sponge test, breath test, and miRNA test with no surveillance from a healthcare payer perspective over a lifetime. Non-invasive strategies were assessed as primar...

12
Glutamate Dehydrogenase as a Superior Biomarker for Choledocholithiasis Risk Stratification
2026-02-17 gastroenterology 10.64898/2026.02.14.26346323
Top 0.7% (5.2%)
Show abstract

Background and AimsCholedocholithiasis (CDL) is a common condition that can lead to serious complications, requiring effective risk stratification for timely intervention. While current guidelines use clinical predictors, imaging, and laboratory markers for risk assessment, the role of glutamate dehydrogenase (GLDH) in CDL remains poorly understood. This study aims to evaluate its potential as a clinical biomarker for identifying patients with CDL. MethodsThis single-center cohort study identif...

13
Stability of Microbiome-Derived Fatty Acids in Self-Collected Samples: A Comparative Evaluation of Stool and Blood Matrices
2026-03-06 gastroenterology 10.64898/2026.03.05.26347712
Top 0.8% (4.9%)
Show abstract

Background Short-chain fatty acids (SCFAs) are widely used as functional readouts of gut microbial activity in vivo. The growing adoption of decentralised study designs and self-collection protocols has amplified the need for reliable room-temperature storage and shipment strategies. However, SCFAs volatility and the persistence of post-collection microbial metabolism raise concerns regarding pre-analytical stability and the interpretability of measured concentrations. Methods We assessed the te...

14
The GI-specific Avoidance Scale (GIAS): Development, psychometric validation, and incremental power of a new questionnaire
2026-02-26 gastroenterology 10.64898/2026.02.23.26346871
Top 0.8% (4.8%)
Show abstract

Background and AimsAvoidance of symptom-related situations is common in chronic gastrointestinal (GI) conditions, contributing to greater symptom severity, psychological distress, and reduced quality of life. However, no validated measure exists to comprehensively assess GI-specific avoidance. We developed and validated the GI-specific Avoidance Scale (GIAS), a self-report instrument measuring behavioral and cognitive avoidance specific to GI symptoms. MethodsFollowing literature review and mul...

15
Improving the detection of clinically significant steatotic liver disease using a machine learning algorithm in a real-world primary care population
2026-03-05 gastroenterology 10.64898/2026.03.04.26347631
Top 0.9% (4.2%)
Show abstract

Background and aimsPopulation screening for liver disease in high-risk groups is recommended. Community diagnosis of liver disease is a challenge due to the asymptomatic nature of disease until very advanced stages. Moreover, regional variation in testing availability can result in people with clinically significant liver disease being missed. Machine learning (ML) has been proposed as a method to reduce diagnostic error and automate screening. We present a novel machine learning derived algorit...

16
BEGA-UNet: Boundary-Explicit Guided Attention U-Net with Multi-Scale Feature Aggregation for Colonoscopic Polyp Segmentation
2026-03-05 gastroenterology 10.64898/2026.03.04.26347608
Top 1.0% (4.0%)
Show abstract

Accurate polyp segmentation from colonoscopy images is critical for colorectal cancer prevention, yet the generalization of deep learning models under domain shift remains insufficiently explored. We propose Boundary-Explicit Guided Attention U-Net (BEGA-UNet), a boundary-aware segmentation architecture that introduces explicit edge modeling as a structural inductive bias to enhance both segmentation accuracy and cross-domain robustness. The framework integrates three components: an Edge-Guided ...

17
18F-FDG PET/CT metabolic parameters predict prognosis in pancreatic ductal adenocarcinoma after neoadjuvant chemotherapy
2026-03-03 gastroenterology 10.64898/2026.02.28.26347307
Top 1.0% (4.0%)
Show abstract

This study aimed to evaluate the prognostic value of quantitative analysis of {superscript 1}F-FDG positron emission tomography (PET)/computed tomography (CT) metabolic parameters in patients with pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy (NACT). A retrospective analysis was conducted on the clinical and imaging data of 44 patients with pathologically confirmed PDAC who received NACT. All patients completed standard chemotherapy regimens and underwent {superscript 1}...

18
Analysis Of Clinicopathological Histomorphological And Molecular Differences In Right And Left Sided Colonic Carcinoma
2026-03-04 health systems and quality improvement 10.64898/2026.03.03.26347325
Top 1% (3.7%)
Show abstract

BackgroundColorectal carcinoma (CRC) remains a significant cause of cancer morbidity and mortality worldwide. Right- and left-sided tumours differ in clinical, morphological, and molecular features. Microsatellite instability-high (MSI-H) tumours, often right-sided, are associated with distinct histopathological characteristics and prognostic implications. In Sri Lanka, molecular MSI testing is currently unavailable, highlighting the need for alternative predictive approaches. ObjectivesGeneral...

19
Elevated suicidal thoughts and behaviors among adults reporting symptoms of Cannabinoid Hyperemesis Syndrome: Results from a national survey of US adults
2026-02-28 gastroenterology 10.64898/2026.02.26.26347185
Top 1% (2.1%)
Show abstract

ObjectiveAs cannabis use has increased in the United States, so has cannabinoid hyperemesis syndrome (CHS), a disorder characterized by severe nausea, vomiting, and abdominal pain among heavy cannabis users. We previously showed that CHS symptoms are associated with several behavioral and psychological characteristics linked to psychosocial impairment. We examined links between CHS symptoms and suicidal thoughts, behaviors, and proximal suicide risk factors. MethodsWe used data from the Nationa...

20
Association Between Clostridioides difficile Test Positivity and Incident Colorectal Cancer in a Multisite Hospital-Based Retrospective Cohort Analysis
2026-02-24 epidemiology 10.64898/2026.02.19.26346648
Top 1% (2.0%)
Show abstract

IntroductionSporadic colorectal cancer (CRC) remains a significant driver of worldwide morbidity and mortality. Environmental factors associated with CRC are increasingly well-described and now include generalized colonic dysbiosis and individual enteric bacteria. Clostridioides difficile is one such species, with recent mouse model work suggesting prolonged exposure to C. difficile toxin B is conducive to colonic tumorigenesis. However, there is a dearth of real-world human evidence linking C. ...